Compas Logo
Back

Can describe the common or important adverse effects, including important drug interactions, of the systemic treatments commonly used in the index dermatological conditions.

Level

This learning outcome is a primary level outcome.

Sessions

This learning outcome is taught in the following sessions:

Assessment

This learning outcome is assessed in the following ways:

  • MBBS Pt 4 (Yr 4)
  • Section B - Examination
  • Section C - Data Interpretation
  • Section D - OSCE Examination

Barts and The London - School of Medicine and Dentistry

© 2011 Barts and The London
School of Medicine and Dentistry

Mobile design and development by Studio 24